tiprankstipranks
Advertisement
Advertisement

OMER Stock Latest News

Omeros options imply 9.8% move in share price post-earnings
The FlyOmeros options imply 9.8% move in share price post-earnings
26d ago
OMER
Omeros reports Q2 adjusted EPS 2c vs (24c) last year
PremiumThe Fly
Omeros reports Q2 adjusted EPS 2c vs (24c) last year
26d ago
OMER
Closing Bell Movers: Cerebras slips 16% after wider Q2 loss
PremiumThe Fly
Closing Bell Movers: Cerebras slips 16% after wider Q2 loss
26d ago
GO
ENS
Midday Fly By: Cisco reports Q4 beat, Pershing Square takes Netflix stake
PremiumThe Fly
Midday Fly By: Cisco reports Q4 beat, Pershing Square takes Netflix stake
26d ago
F
V
Omeros’ $100 Million Buyback Plan: How Discretionary Repurchases Could Distort Share Price and Heighten Volatility
PremiumCompany Announcements
Omeros’ $100 Million Buyback Plan: How Discretionary Repurchases Could Distort Share Price and Heighten Volatility
29d ago
OMER
Omeros Appoints Veteran Investor Joseph Schocken to Board
PremiumCompany AnnouncementsOmeros Appoints Veteran Investor Joseph Schocken to Board
29d ago
8K
OMER
Omeros Maintained at Buy as Strong YARTEMLEA Launch and Reduced C5 Competition Support Unchanged $33 Price Target
Premium
Ratings
Omeros Maintained at Buy as Strong YARTEMLEA Launch and Reduced C5 Competition Support Unchanged $33 Price Target
30d ago
OMER
Omeros Earnings Call: Yartemlia Surge and Leaner Balance Sheet
Premium
Company Announcements
Omeros Earnings Call: Yartemlia Surge and Leaner Balance Sheet
1M ago
OMER
Omeros grants new technology add-on payment status to Yartemlea
PremiumThe Fly
Omeros grants new technology add-on payment status to Yartemlea
1M ago
OMER
Midday Fly By: Argenx to buy Forte, Nvidia in talks for $250B OpenAI backstop
PremiumThe Fly
Midday Fly By: Argenx to buy Forte, Nvidia in talks for $250B OpenAI backstop
2M ago
F
GM
Omeros Buy Rating Reiterated as Ultomiris Setback Eases Competitive Risk; $33 Price Target Maintained
PremiumRatings
Omeros Buy Rating Reiterated as Ultomiris Setback Eases Competitive Risk; $33 Price Target Maintained
2M ago
OMER
AstraZeneca miss ‘clear positive’ for Omeros, says H.C. Wainwright
PremiumThe Fly
AstraZeneca miss ‘clear positive’ for Omeros, says H.C. Wainwright
2M ago
AZN
OMER
Omeros up 11% to $10.89 after AstraZeneca study failure
PremiumThe FlyOmeros up 11% to $10.89 after AstraZeneca study failure
2M ago
AZN
OMER
Omeros Reduces Convertible Debt Through Note Repurchases
Premium
Company Announcements
Omeros Reduces Convertible Debt Through Note Repurchases
2M ago
8K
OMER
Omeros Announces Major Convertible Notes Repurchase Plan
Premium
Company Announcements
Omeros Announces Major Convertible Notes Repurchase Plan
2M ago
8K
OMER
Buy Rating Maintained on YARTEMLEA as Analyst Trims Price Target to $33 but Sees U.S. Launch Driving Upside
PremiumRatings
Buy Rating Maintained on YARTEMLEA as Analyst Trims Price Target to $33 but Sees U.S. Launch Driving Upside
3M ago
OMER
Omeros price target lowered to $33 from $40 at H.C. Wainwright
PremiumThe Fly
Omeros price target lowered to $33 from $40 at H.C. Wainwright
3M ago
OMER
Analyst Maintains Hold on Omeros, Raises Price Target to $10.72 Despite European Regulatory Setback
PremiumRatings
Analyst Maintains Hold on Omeros, Raises Price Target to $10.72 Despite European Regulatory Setback
3M ago
OMER
Omeros announces CHMP adopts negative opinion on MAA for narsoplimab
PremiumThe Fly
Omeros announces CHMP adopts negative opinion on MAA for narsoplimab
3M ago
OMER
Omeros Plans Repurchase of Convertible Senior Notes
PremiumCompany AnnouncementsOmeros Plans Repurchase of Convertible Senior Notes
3M ago
8K
OMER
Omeros trading resumes
Premium
The Fly
Omeros trading resumes
3M ago
OMER
Omeros trading halted, volatility trading pause
Premium
The Fly
Omeros trading halted, volatility trading pause
3M ago
OMER

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >